节点文献

Graves病131I治疗的研究进展

Research Progress in 131I Treatment for the Graves Disease

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王朋代文莉胡涛严凯胡伟崔邦平

【Author】 WANG Peng;DAI Wen-li;HU Tao;YAN Kai;HU Wei;CUI Bang-ping;The First College of Clinical Medical Science,China Three Gorges University/Yichang Central People’s Hospital/Yichang Nuclear Medicine and Molecular Image Key Laboratory;

【机构】 三峡大学第一临床医学院宜昌市中心人民医院核医学科宜昌市核医学分子影像重点实验室

【摘要】 Graves病(GD)是由多种原因引起的甲状腺激素分泌过多,导致机体代谢异常增高、功能紊乱,甚至组织器官损害的综合征。目前,GD有内科药物治疗、外科手术治疗、核医学131I治疗三种成熟的治疗方法。核医学131I治疗以其独特优势已经被越来越多的患者和临床医师所接受,成为最常用的治疗方法之一。熟悉治疗原理、正确选择适应证、合理制订给药剂量、预防可能的不良结局,是GD131I治疗的基础。

【Abstract】 Graves disease( GD) is a common endocrine disease,which accounts for the majority of the hyperthyroidism. GD is a syndrome caused by a variety of reasons of thyroid hormone hypersecretion,leading to syndromes of abnormal metabolic increase,functional disorders of the body,and even organs injury. At present,there are three matured treatments for the GD: internal medicine,surgery and nuclear medicine131 I treatment. And nuclear medicine131 I treatment has become one of the most commonly used methods due to its unique advantages. Understanding the principle of treatment,correct selection of indications,reasonable calculation of the dose and prevention of adverse outcomes are the foundation of the GD131 I treatment.

【基金】 宜昌市科学研究与开发项目(A13301-12)
  • 【文献出处】 医学综述 ,Medical Recapitulate , 编辑部邮箱 ,2015年12期
  • 【分类号】R581.1;R817.5
  • 【被引频次】3
  • 【下载频次】255
节点文献中: 

本文链接的文献网络图示:

本文的引文网络